View in EDS HTML Full Text PDF Full Text

US Severe Acute Respiratory Syndrome Coronavirus 2 Epsilon Variant: Highly Transmissible but With an Adjusted Muted Host T-Cell Response.

Saved in:
Bibliographic Details
Title: US Severe Acute Respiratory Syndrome Coronavirus 2 Epsilon Variant: Highly Transmissible but With an Adjusted Muted Host T-Cell Response.
Authors: Plummer JT; Center for Bioinformatics and Functional Genomics, Cedars-Sinai Medical Center, Los Angeles, California, USA.; Applied Genomics, Computation & Translational Core, Cedars-Sinai Cancer, Cedars-Sinai Medical Center, Los Angeles, California, USA.; Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, California, USA., Contreras D; Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, California, USA.; Clinical Microbiology Laboratory, Cedars-Sinai Medical Center, Los Angeles, California, USA., Zhang W; Department of Pathology & Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, California, USA.; Molecular Pathology Laboratory, Cedars-Sinai Medical Center, Los Angeles, California, USA., Binek A; Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA.; Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California, USA.; Advanced Clinical Biosystems Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA., Zhang R; Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California, USA.; HLA and Transplant Immunology Laboratory, Cedars-Sinai Medical Center, Los Angeles, California, USA., Dezem F; Center for Bioinformatics and Functional Genomics, Cedars-Sinai Medical Center, Los Angeles, California, USA.; Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, California, USA., Chen SS; Center for Bioinformatics and Functional Genomics, Cedars-Sinai Medical Center, Los Angeles, California, USA.; Applied Genomics, Computation & Translational Core, Cedars-Sinai Cancer, Cedars-Sinai Medical Center, Los Angeles, California, USA.; Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, California, USA., Davis BD; Center for Bioinformatics and Functional Genomics, Cedars-Sinai Medical Center, Los Angeles, California, USA.; Applied Genomics, Computation & Translational Core, Cedars-Sinai Cancer, Cedars-Sinai Medical Center, Los Angeles, California, USA.; Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, California, USA., Sincuir Martinez J; Department of Pathology & Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, California, USA.; Molecular Pathology Laboratory, Cedars-Sinai Medical Center, Los Angeles, California, USA., Stotland A; Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA.; Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California, USA.; Advanced Clinical Biosystems Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA., Kreimer S; Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA.; Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California, USA.; Advanced Clinical Biosystems Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA., Makhoul E; Department of Pathology & Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, California, USA.; Molecular Pathology Laboratory, Cedars-Sinai Medical Center, Los Angeles, California, USA., Heneidi S; Department of Pathology & Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, California, USA.; Molecular Pathology Laboratory, Cedars-Sinai Medical Center, Los Angeles, California, USA., Eno C; Department of Pathology & Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, California, USA.; Molecular Pathology Laboratory, Cedars-Sinai Medical Center, Los Angeles, California, USA., Shin B; Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California, USA.; HLA and Transplant Immunology Laboratory, Cedars-Sinai Medical Center, Los Angeles, California, USA., Berg AH; Department of Pathology & Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, California, USA.; Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California, USA., Cheng S; Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA.; Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California, USA., Jordan SC; Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California, USA.; HLA and Transplant Immunology Laboratory, Cedars-Sinai Medical Center, Los Angeles, California, USA., Vail E; Department of Pathology & Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, California, USA.; Molecular Pathology Laboratory, Cedars-Sinai Medical Center, Los Angeles, California, USA., Van Eyk JE; Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA.; Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California, USA.; Advanced Clinical Biosystems Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA., Morgan MA; Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, California, USA.; Clinical Microbiology Laboratory, Cedars-Sinai Medical Center, Los Angeles, California, USA.
Corporate Authors: CORALE Study Group
Source: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2022 Nov 30; Vol. 75 (11), pp. 1940-1949.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print Cited Medium: Internet ISSN: 1537-6591 (Electronic) Linking ISSN: 10584838 NLM ISO Abbreviation: Clin Infect Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1537-6591
DOI:10.1093/cid/ciac295